Do not share your Ozempic® pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
Diabetes Savings Card Program
Novo Nordisk Savings Card
Eligibility and Restrictions:
In order to redeem this offer, patient must have a valid prescription for the brand being filled. A valid Prescriber ID# is required on the prescription. Patient is not eligible if he/she participates in or seeks reimbursement or submits a claim for reimbursement to any federal or state health care program with prescription drug coverage, such as Medicaid, Medicare, Medigap, VA, DOD, TRICARE, or any similar federal or state health care program (each a Government Program), or where prohibited by law. Patient must be enrolled in, and must seek reimbursement from or submit a claim for reimbursement to, a commercial insurance plan. The brand and the prescription being filled must be covered by the patient’s commercial insurance plan. Offer excludes full cash-paying patients. This offer may not be redeemed for cash. By using this offer, you are certifying that you meet the eligibility criteria and will comply with the terms and conditions described herein and will not seek reimbursement for any benefit received through this card. Novo Nordisk’s Eligibility and Restrictions, and Offer Details may change from time to time, and for the most recent version, please visit this webpage. Re-confirmation of information may be requested periodically to ensure accuracy of data and compliance with terms. Patients with questions about the Savings Card offer may call 1-877-304-6855.
This offer is valid in the United States and may be redeemed at participating retail pharmacies. Availability of the Savings Offer in Massachusetts will be dependent upon state law in effect at the time patient presents the Savings Offer when paying for the covered medications.
This offer is not transferable and is limited to one offer per person. Not valid if reproduced.
Cash Discount Cards and other non-insurance plans are not valid as primary insurance under this offer. If the patient is eligible for drug benefits under any such program, the patient cannot use this offer. This Savings Card cannot be combined with any coupon, certificate, voucher, or similar offer.
Patient is responsible for complying with any insurance carrier co-payment disclosure requirements, including disclosing any savings received from this program. It is illegal to (or offer to) sell, purchase, or trade this offer.
This program is managed by ConnectiveRx on behalf of Novo Nordisk. The parties reserve the right to rescind, revoke or amend this offer without notice at any time.
This offer is good for eligible patients purchasing up to a 90-day supply.
(a) NOVOLOG® (insulin aspart) injection 100 U/mL or NOVOLOG® MIX 70/30 (insulin aspart protamine and insulin aspart) injectable suspension 100 U/mL: Pay as little as (“PALA”) $25 per 30-day, $50 per 60-day, or $75 per 90-day supply for up to 24 months from the date of Savings Card activation, subject to a maximum savings of $100 per 30-day (“Savings Benefit”), $200 per 60-day, or $300 per 90-day supply.
(b) FIASP® (insulin aspart injection) 100 U/mL: Pay as little as (“PALA”) $25 per 30-day, $50 per 60-day, or $75 per 90-day supply for up to 24 months from the date of Savings Card activation, subject to a maximum savings of $150 per 30-day, $300 per 60-day, or $450 per 90-day supply.
(c) OZEMPIC® (semaglutide) injection 0.5 mg or 1 mg: Pay as little as (“PALA”) $25 per 1-month prescription, $50 per 2-month prescription, or $25 per 3-month prescription for up to 24 months from the date of Savings Card activation, subject to a maximum savings of $150 per 1-month prescription, $300 per 2-month prescription, $450 per 3-month prescription. Month is defined as 28 days. In order to obtain the “PALA $25 per 3-month prescription” offer, the patient must have a prescription for a 3-month supply, and the patient’s commercial insurance plan must provide coverage for a 3-month fill.
(d) RYBELSUS® (semaglutide) tablets 7 mg or 14 mg:
If your commercial insurance plan does not cover RYBELSUS®, use of this offer permits your healthcare provider or pharmacy to share limited information with ConnectiveRx and CoverMyMeds to act on your behalf to initiate any paperwork or processes that may be necessary so that you may continue to have access to therapy.
When you apply this offer, you are certifying that you have not submitted a claim for reimbursement under any Government Program for this prescription, or where prohibited by law. Participation in this program must comply with all applicable laws and regulations as a pharmacy provider. By participating in this program, you are certifying that you will comply with the eligibility criteria, and terms and conditions described herein. You also certify that you will not seek reimbursement for any benefit received through this card.
Pharmacist instructions for a patient with an Eligible Third Party:
Submit the claim to the primary Third Party Payer first, then submit the balance due to CHANGE HEALTHCARE as a Secondary Payer COB [coordination of benefits] with patient responsibility amount and a valid Other Coverage Code, (eg, 8). The patient is responsible initially for the PALA amount and the card pays up to the Savings Benefit. Offer excludes full cash-paying patients. Reimbursement will be received from CHANGE HEALTHCARE. For any questions regarding CHANGE HEALTHCARE online processing, please call the Help Desk at 1–800–433–4893.